Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Sema4, Sophia Genetics, Qiagen, More

Sema4: Isaac Ro

Isaac Ro has been appointed as CFO of Sema4. Previously, he was CFO of Thrive Earlier Detection, which was recently acquired by Exact Sciences. Prior to that, he led the US medical technology team at Goldman Sachs, where he covered life science tools, diagnostics, and medical technology. Before that, he held a similar role at SVB Leerink.


Sophia Genetics: Ross Muken

Sophia Genetics has named Ross Muken as chief financial officer. Muken, who has more than two decades of experience in finance, previously had been CFO and COO of Click Therapeutics. He has also had stints as head of healthcare services and technology research at Evercore ISI and in equity research at Thomas Weisel Partners.


Qiagen: Toralf Haag

Qiagen said this week that it has appointed Toralf Haag as a member of the supervisory board and audit committee. Since October 2018 Haag has served as CEO and chairman of management board at Voith, a global technology company. Before joining Voith, he served for more than 11 years at Lonza as CFO and a member of the executive committee.


For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.